[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

C59H52N4OPt — CID 171724119

IUPAC[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(c(C)c5C)CC7)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C59H52N4O.Pt/c1-38-31-58(60-35-54(38)44-19-24-47(25-20-44)59(4,5)6)63-55-30-23-46(43-11-8-7-9-12-43)32-53(55)52-29-28-51(34-56(52)63)64-50-14-10-13-49(33-50)61-36-57-45-18-17-41-15-16-42(40(3)39(41)2)21-26-48(27-22-45)62(57)37-61;/h7-16,19-20,22-25,27-36H,17-18,21,26H2,1-6H3;
InChIKeyMGVNVNTZBAETRH-UHFFFAOYSA-N
MW1028.17 g/mol
LogP14.53
Rot. Bonds6

About [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (PubChem CID 171724119) has the molecular formula C59H52N4OPt and a molecular weight of 1028.17 g/mol. Its IUPAC name is [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.

Molecular Properties

Compound Name[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
PubChem CID171724119
Molecular FormulaC59H52N4OPt
Molecular Weight1028.17 g/mol
Exact Mass1027.38
IUPAC Name[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(c(C)c5C)CC7)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C59H52N4O.Pt/c1-38-31-58(60-35-54(38)44-19-24-47(25-20-44)59(4,5)6)63-55-30-23-46(43-11-8-7-9-12-43)32-53(55)52-29-28-51(34-56(52)63)64-50-14-10-13-49(33-50)61-36-57-45-18-17-41-15-16-42(40(3)39(41)2)21-26-48(27-22-45)62(57)37-61;/h7-16,19-20,22-25,27-36H,17-18,21,26H2,1-6H3;
InChIKeyMGVNVNTZBAETRH-UHFFFAOYSA-N
XLogP14.53
TPSA36.39 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001028.17
LogP ≤ 514.53
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The IUPAC name of [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (CID 171724119) is [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.
What is the SMILES notation for [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The canonical SMILES for [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is Cc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(c(C)c5C)CC7)c4)cc32)ncc1-c1ccc(C(C)(C)C)cc1.
What is the InChIKey of [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The InChIKey is MGVNVNTZBAETRH-UHFFFAOYSA-N. The full InChI is InChI=1S/C59H52N4O.Pt/c1-38-31-58(60-35-54(38)44-19-24-47(25-20-44)59(4,5)6)63-55-30-23-46(43-11-8-7-9-12-43)32-53(55)52-29-28-51(34-56(52)63)64-50-14-10-13-49(33-50)61-36-57-45-18-17-41-15-16-42(40(3)39(41)2)21-26-48(27-22-45)62(57)37-61;/h7-16,19-20,22-25,27-36H,17-18,21,26H2,1-6H3;.
What are the key properties of [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
[13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum has a molecular weight of 1028.17 g/mol, XLogP of 14.53, 6 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [13-[3-[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-6-phenylcarbazol-2-yl]oxyphenyl]-5,6-dimethyl-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is sourced from PubChem (CID 171724119), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).